Transplantation of kidneys from donors at increased risk for Blood-borne viral infection: Recipient outcomes and patterns of organ use

American Journal of Transplantation

Volumn 9, Issue 10, 2009, Pages 2338-2345

  Reese, P P ^a,b,c   Feldman, H I ^a,b   Asch, D A ^c,d   Halpern, S D ^a,b,c   Blumberg, E A ^c   Thomasson, A ^b   Shults, J ^b   Bloom, R D ^a  

^a Renal Division   (United States)

^b Center for Clinical Epidemiology and Biostatistics   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Centers for Disease Control (CDC); Kidney transplantation; Viral infection

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; ARTICLE; CADAVER KIDNEY; COHORT ANALYSIS; FEMALE; GRAFT FAILURE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; TREATMENT OUTCOME; VIRUS INFECTION;

BLOOD-BORNE PATHOGENS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COHORT STUDIES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES; VIRUS DISEASES;

EID: 70349196674     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02782.x     Document Type: Article

References (23)

1. Merion RM, Ashby VB, Wolfe RA et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005 294 : 2726 2733.
2. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol 2006 1 : 532 538.
3. Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA. Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation. Am J Transplant 2007 7 : 1797 1807.
4. Ho KJ, Owens CD, Johnson SR et al. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation 2008 85 : 1588 1594.
5. Saidi RF, Elias N, Kawai T et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs. Am J Transplant 2007 7 : 2769 2774.
6. Schweitzer EJ, Perencevich EN, Philosophe B, Bartlett ST. Estimated benefits of transplantation of kidneys from donors at increased risk for HIV or hepatitis C infection. Am J Transplant 2007 7 : 1515 1525.
7. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994 43 : 1 17.
8. Fishman JA, Greenwald MA, Kuehnert MJ. Enhancing transplant safety: A new era in the microbiologic evaluation of organ donors? Am J Transplant 2007 7 : 2652 2654.
9. Fishman JA. Informing candidates for transplantation about donor risk factors. N Engl J Med 2008 359 : 1182 author reply 1183.
10. Zou S, Dodd RY, Stramer SL, Strong DM. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004 351 : 751 759.
11. Grady D. Four transplant recipients contract HIV. New York Times November 13 2007.
12. USRDS. Reference table: Patient survival. Bethesda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2008 [updated 2008; cited]; Available from : http://www.usrds.org/adr. htm.
13. Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy KR. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 2005 5 : 139 144.
14. Szczech LA, Berlin JA, Feldman HI. The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group. Ann Intern Med 1998 128 : 817 826.
15. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999 341 : 1725 1730.
16. Ojo AO, Hanson JA, Meier-Kriesche H et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001 12 : 589 597.
17. CBS. Chicago organ recipients infected with HIV. Published: November 13, 2007. http://wcco.com/national/HIV.organ.transplant.2.566338.html
18. Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008 358 : 2832 2837.
19. Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008 52 : 553 586.
20. Baillargeon J, Black SA, Pulvino J, Dunn K. The disease profile of Texas prison inmates. Ann Epidemiol 2000 10 : 74 80.
21. Lindquist CH, Lindquist CA. Health behind bars: Utilization and evaluation of medical care among jail inmates. J Community Health 1999 24 : 285 303.
22. Martin RE, Gold F, Murphy W, Remple V, Berkowitz J, Money D. Drug use and risk of bloodborne infections: A survey of female prisoners in British Columbia. Can J Public Health 2005 96 : 97 101.
23. Kucirka LM, Alexander C, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs. Am J Transplant 2009 9 : 620 628.